CompletedNot Applicable

Effectiveness of Serratiopeptidase After Mandibular Third Molar Surgery

Pakistan110 participantsStarted 2025-06-06

Plain-language summary

This randomized controlled trial was conducted to compare the effect of serratiopeptidase versus no intervention on postoperative mouth opening, swelling, and trismus following surgical removal of mesioangular mandibular third molars.

Who can participate

Age range

18 Years – 40 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Patients aged 18 to 40 years. Patients requiring surgical removal of a mesioangular impacted mandibular third molar. Patients who are systemically healthy (ASA I or II). Patients willing to participate and provide written informed consent. Patients who can comply with postoperative follow-up visits. Exclusion Criteria: * Patients with systemic diseases affecting healing (e.g., diabetes, immunocompromised state). Pregnant or lactating women. Patients with known allergy or hypersensitivity to serratiopeptidase. Patients on long-term anti-inflammatory or steroid medication. Presence of acute infection at the surgical site. Patients who have taken anti-inflammatory drugs within 48 hours before surgery.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Postoperative Facial Swelling

Timeframe: Postoperative Day 1, Day 3, and Day 7

Trial details

NCT IDNCT07543146

SponsorSharif Medical Research Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-09-02

View on ClinicalTrials.gov More Trismus trials

Who can participate

Age range

18 Years – 40 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.